Literature DB >> 30237103

Monovision: Consequences for depth perception from large disparities.

Carrie E Smith1, Robert S Allison2, Frances Wilkinson1, Laurie M Wilcox1.   

Abstract

Recent studies have confirmed that monovision treatment degrades stereopsis but it is not clear if these effects are limited to fine disparity processing, or how they are affected by viewing distance or age. Given the link between stereopsis and postural stability, it is important that we have full understanding of the impact of monovision on binocular function. In this study we assessed the short-term effects of optically induced monovision on a depth-discrimination task for young and older (presbyopic) adults. In separate sessions, the upper limits of stereopsis were assessed with participants' best optical correction and with monovision (-1D and +1D lenses in front of the dominant and non-dominant eyes respectively), at both near (62 cm) and far (300 cm) viewing distances. Monovision viewing resulted in significant reductions in the upper limit of stereopsis or more generally in discrimination performance at large disparities, in both age groups at a viewing distance of 300 cm. Dynamic photorefraction performed on a sample of four young observers revealed that they tended to accommodate to minimize blur in one eye at the expense of blur in the other. Older participants would have experienced roughly equivalent blur in the two eyes. Despite this difference, both groups displayed similar detrimental effects of monovision. In addition, we find that discrimination accuracy was worse with monovision at the 3 m viewing distance which involves fixation distances that are typical during walking. These data suggest that stability during locomotion may be compromised, a factor that is of concern for our older participants.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Depth perception; Monovision; Presbyopia; Stereoacuity; Stereopsis; Upper disparity limit

Mesh:

Year:  2018        PMID: 30237103     DOI: 10.1016/j.exer.2018.09.005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  2 in total

Review 1.  Pharmacological Treatment in Presbyopia.

Authors:  Andrzej Grzybowski; Varis Ruamviboonsuk
Journal:  J Clin Med       Date:  2022-03-03       Impact factor: 4.241

2.  Multifocal Femto-PresbyLASIK in Pseudophakic Eyes.

Authors:  Bojan Pajic; Horace Massa; Philipp B Baenninger; Erika Eskina; Brigitte Pajic-Eggspuehler; Mirko Resan; Zeljka Cvejic
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.